SCHEMBL4959416

SCHEMBL4959416

O=C(O)C1C=CC=C(O)C1O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14648918 0.77 TSHR (0.37) TSHRMAPK1HSD17B10TDP1
SCHEMBL28101799 0.77 TSHR (0.37) TSHRMAPK1HSD17B10TDP1
SCHEMBL172436 0.69
SCHEMBL156544 0.67 POLB (0.36) TDP1
SCHEMBL11579330 0.67 POLB (0.36) TDP1
SCHEMBL29519432 0.67
Ammonia Solution, Strong SCHEMBL29216790 0.65 POLB (0.35) TDP1
SCHEMBL9695864 0.65 POLB (0.35) TDP1
Water SCHEMBL27554144 0.65 POLB (0.35) TDP1
Ammonia Solution, Strong SCHEMBL29216789 0.65 POLB (0.35) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035826-B2 Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2018-07-31 US disclosed
US-20160244489-A1 PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS/SEPSIS-ASSOCIATED ESCHERICHIA COLI GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2016-08-25 US disclosed
US-9334313-B2 Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2016-05-10 US disclosed
US-20140356389-A1 PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS/SEPSIS-ASSOCIATED ESCHERICHIA COLI J. CRAIG VENTER INSTITUTE, INC. (US) 2014-12-04 US disclosed
US-8758764-B2 Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) 2014-06-24 US disclosed
US-20080193470-A1 For immunizing against MNEC infections GLAXOSMITHKLINE VACCINES S.R.L. (BE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140356389-A1 PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS/SEPSIS-ASSOCIATED ESCHERICHIA COLI SNRPE, NSUN3, DNASE1 TSHR 4646/4885MAPK1 2686/4885HSD17B10 4543/4885
US-10035826-B2 Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli SNRPE, NSUN3, DNASE1 TSHR 4638/4885MAPK1 2693/4885HSD17B10 4548/4885
US-20160244489-A1 PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS/SEPSIS-ASSOCIATED ESCHERICHIA COLI SNRPE, NSUN3, DNASE1 TSHR 4646/4885MAPK1 2686/4885HSD17B10 4543/4885
US-20080193470-A1 For immunizing against MNEC infections MLEC, GMFG, MYD88 TSHR 4752/4885MAPK1 2922/4885HSD17B10 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.